Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equivalence study of serum-free bioreactor versus roller-bottle manufactured darbepoetin alfa in anemia of chronic kidney disease on hemodialysis
2004-004178-10Phase 3Completed
- Sponsor
- Amgen
- Start
- Dec 2004
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of darbepoetin alfa in anaemia, chronic kidney disease (CKD), sponsored by Amgen. Started Dec 2004; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anaemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on 2004-004178-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004178-10.